Multicenter validation of FIB-6 as a novel machine learning non-invasive score to rule out liver cirrhosis in biopsy-proven MAFLD

aDigestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

bLiver Disease Research Center, Department of Medicine, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia

cDepartment of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece

dDepartment of Internal Medicine, Gastroenterology and Hepatology İstanbul Health and Technology University, Istanbul, Türkiye

eDepartment of Medicine, Division of Gastroenterology and Hepatology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

fGastroenterology Unit, Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia

gGastroenterology and Hepatology Department, Egyptian Liver Research Institute and Hospital (ELRIAH), Sherbin, El-Mansoura

hBiostatistics and Cancer Epidemiology Department, South Egypt Cancer Institute, Assiut University, Assuit

iTropical Medicine Department, Faculty of Medicine, Port Said University, Port Said

jHepatology and Gastroenterology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

Received 5 April 2023 Accepted 2 June 2023.

Correspondence to Prof. Gamal Shiha, Internal Medicine Department, Faculty of Medicine, Mansoura University, Egypt, Tel: +201212222765; e-mail: [email protected]

Comments (0)

No login
gif